In recent years, the significant growth of the dietary supplement market and of product innovation have encouraged an increase in clinical trials supporting the safety and biomedical validity of these types of products.
The Group's R&D division is constantly engaged in devising and innovating products and production processes, while at the same time translating and anticipating the needs of its customers. The team consists of 50 professionals from the cosmetics, dietary supplements and medical devices areas, and also includes a team dedicated to regulatory affairs.
Thanks to its collaboration with research centers, universities and start-ups at regional and national levels, Biofarma Group develops more than 2,000 projects annually, many of which become highly innovative products capable of establishing themselves in the market as leaders in quality, supported by clinical studies attesting to the effectiveness of the formulations.
|
|
